Aurea Mediocritas: The Importance of a Balanced Genome

Cold Spring Harbor Perspectives in Biology

Volumn 6, Issue 11, 2014, Pages 1-20

  Varetti, Gianluca ^a,b   Pellman, David ^a,b,c   Gordon, David J ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; CARCINOGENESIS; CHROMATID; CHROMOSOMAL INSTABILITY; GENETICS; GENOME; M PHASE CELL CYCLE CHECKPOINT; METABOLISM; NEOPLASM;

ANEUPLOIDY; CARCINOGENESIS; CHROMATIDS; CHROMOSOMAL INSTABILITY; GENOME; M PHASE CELL CYCLE CHECKPOINTS; NEOPLASMS;

EID: 84908399122     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a015842     Document Type: Article

References (146)

1. Andrews PD, Ovechkina Y, Morrice N, Wagenbach M, Duncan K, Wordeman L, Swedlow JR. 2004. Aurora B regulates MCAK at the mitotic centromere. Dev Cell 6: 253-268.
2. Babu JR, Jeganathan KB, Baker DJ, Wu X, Kang-Decker N, van Deursen JM. 2003. Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation. J Cell Biol 160: 341-353.
3. Baek KH, Zaslavsky A, Lynch RC, Britt C, Okada Y, Siarey RJ, Lensch MW, Park IH, Yoon SS, Minami T, et al. 2009. Down’s syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature 459: 1126-1130.
4. Baker DJ, Jeganathan KB, Cameron JD, Thompson M, Juneja S, Kopecka A, Kumar R, Jenkins RB, de Groen PC, Roche P, et al. 2004. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nat Genet 36: 744-749.
5. Baker DJ, Jeganathan KB, Malureanu L, Perez-Terzic C, Terzic A, van Deursen JM. 2006. Early aging-associated phenotypes in Bub3/Rae1 haploinsufficient mice. J Cell Biol 172: 529-540.
6. Baker DJ, Jin F, Jeganathan KB, van Deursen JM. 2009. Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity. Cancer Cell 16: 475-486.
7. Bakhoum SF, Genovese G, Compton DA. 2009a. Deviant kinetochore microtubule dynamics underlie chromosomal instability. Curr Biol 19: 1937-1942.
8. Bakhoum SF, Thompson SL, Manning AL, Compton DA. 2009b. Genome stability is ensured by temporal control of kinetochore-microtubule dynamics. Nat Cell Biol 11: 27-35.
9. Barber TD, McManus K, Yuen KW, Reis M, Parmigiani G, Shen D, Barrett I, Nouhi Y, Spencer F, Markowitz S, et al. 2008. Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers. Proc Natl Acad Sci 105: 3443-3448.
10. Belkov VM, Krynetski EY, Schuetz JD, Yanishevski Y, Masson E, Mathew S, Raimondi S, Pui CH, Relling MV, Evans WE. 1999. Reduced folate carrier expression in acute lymphoblastic leukemia: A mechanism for ploidy but not lineage differences in methotrexate accumulation. Blood 93: 1643-1650.
11. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, et al. 2010. The landscape of somatic copy-number alteration across human cancers. Nature 463: 899-905.
12. Bianchi AB, Aldaz CM, Conti CJ. 1990. Nonrandom duplication of the chromosome bearing a mutated Ha-ras-1 allele in mouse skin tumors. ProcNatl Acad Sci 87: 6902-6906.
13. Brito DA, Rieder CL. 2006. Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint. Curr Biol 16: 1194-1200.
14. Burrell RA, McClelland SE, Endesfelder D, Groth P, Weller MC, Shaikh N, Domingo E, Kanu N, Dewhurst SM, Gronroos E, et al. 2013. Replication stress links structural and numerical cancer chromosomal instability. Nature 494: 492-496.
15. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B. 1998.Mutations of mitotic checkpoint genes in human cancers. Nature 392: 300-303.
16. Carter SL, Cibulskis K, Helman E, McKenna A, Shen H, Zack T, Laird PW, Onofrio RC, Winckler W, Weir BA, et al. 2012. Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol 30: 413-421.
17. Cassimeris L, Morabito J. 2004. TOGp, the human homolog of XMAP215/Dis1, is required for centrosome integrity, spindle pole organization, and bipolar spindle assembly. Mol Biol Cell 15: 1580-1590.
18. Chandhok NS, Pellman D. 2009. A little CIN may cost a lot: Revisiting aneuploidy and cancer. Curr Opin Genet Dev 19: 74-81.
19. Cheng Y, Wang H, Wang H, Chen Z, Jin J. 2009. Trisomy 21 in patients with acute leukemia. Am J Hematol 84: 193-194.
20. Cimini D. 2008. Merotelic kinetochore orientation, aneuploidy, and cancer. Biochim Biophys Acta 1786: 32-40.
21. Cimini D, Tanzarella C, Degrassi F. 1999. Differences in malsegregation rates obtained by scoring ana-telophases or binucleate cells. Mutagenesis 14: 563-568.
22. Cimini D, Howell B, Maddox P, Khodjakov A, Degrassi F, Salmon ED. 2001. Merotelic kinetochore orientation is a major mechanism of aneuploidy in mitotic mammalian tissue cells. J Cell Biol 153: 517-527.
23. Cimini D, Moree B, Canman JC, Salmon ED. 2003. Merotelic kinetochore orientation occurs frequently during early mitosis in mammalian tissue cells and error correction is achieved by two different mechanisms. J Cell Sci 116: 4213-4225.
24. Cimini D, Cameron LA, Salmon ED. 2004. Anaphase spindle mechanics prevent missegregation of merotelically oriented chromosomes. Curr Biol 14: 2149-2155.
25. Crasta K, Ganem NJ, Dagher R, Lantermann AB, Ivanova EV, Pan Y, Nezi L, Protopopov A, Chowdhury D, Pellman D. 2012. DNA breaks and chromosome pulverization from errors in mitosis. Nature 482: 53-58.
26. Dai W, Wang Q, Liu T, Swamy M, Fang Y, Xie S, Mahmood R, Yang YM, Xu M, Rao CV. 2004. Slippage of mitotic arrest and enhanced tumor development in mice with BubR1 haploinsufficiency. Cancer Res 64: 440-445.
27. De Lange T. 2005. Telomere-related genome instability in cancer. Cold Spring Harb Symp Quant Biol 70: 197-204.
28. Diaz-Rodriguez E, Sotillo R, Schvartzman JM, Benezra R. 2008. Hec1 overexpression hyperactivates the mitotic checkpoint and induces tumor formation in vivo. Proc Natl Acad Sci 105: 16719-16724.
29. Dobles M, Liberal V, Scott ML, Benezra R, Sorger PK. 2000. Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2. Cell 101: 635-645.
30. Dorsett D. 2011.Cohesin: Genomic insights into controlling gene transcription and development. Curr Opin Genet Dev 21: 199-206.
31. Duesberg P, Li R, Fabarius A, Hehlmann R. 2006. Aneuploidy and cancer: From correlation to causation. Contrib Microbiol 13: 16-44.
32. Fenech M, Kirsch-Volders M, Natarajan AT, Surralles J, Crott JW, Parry J, Norppa H, Eastmond DA, Tucker JD, Thomas P. 2011. Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells. Mutagenesis 26: 125-132.
33. Fischer J, Palmedo G, von Knobloch R, Bugert P, Prayer-Galetti T, Pagano F, Kovacs G. 1998. Duplication and overexpression of the mutant allele of the MET protooncogene in multiple hereditary papillary renal cell tumours. Oncogene 17: 733-739.
34. Fischer C, Buthe J, Nollau P, Hollerbach S, Schulmann K, Schmiegel W, Wagener C, Tschentscher P. 2001. Enrichment of mutant KRAS alleles in pancreatic juice by subtractive iterative polymerase chain reaction. Lab Invest 81: 827-831.
35. Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, Pellman D. 2005. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 437: 1043-1047.
36. Ganem NJ, Godinho SA, Pellman D. 2009. A mechanism linking extra centrosomes to chromosomal instability. Nature 460: 278-282.
37. Gao YF, Li T, Chang Y, Wang YB, Zhang WN, Li WH, He K, Mu R, Zhen C, Man JH, et al. 2011. Cdk1-phosphorylated CUEDC2 promotes spindle checkpoint inactivation and chromosomal instability. Nat Cell Biol 13: 924-933.
38. Gartner EM, Silverman P, Simon M, Flaherty L, Abrams J, Ivy P, Lorusso PM. 2012. A phase II study of 17-allylamino-17-demethoxygeldanamycin in metastatic or locally advanced, unresectable breast cancer. Breast Cancer Res Treat 131: 933-937.
39. Gasch AP, Spellman PT, Kao CM, Carmel-Harel O, Eisen MB, Storz G, Botstein D, Brown PO. 2000. Genomic expression programs in the response of yeast cells to environmental changes. Mol Biol Cell 11: 4241-4257.
40. Gascoigne KE, Taylor SS. 2008. Cancer cells display profound intra-and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 14: 111-122.
41. Geigl JB, Obenauf AC, Schwarzbraun T, Speicher MR. 2008. Defining “chromosomal instability.” Trends Genet 24: 64-69.
42. Gisselsson D. 2008. Classification of chromosome segregation errors in cancer. Chromosoma 117: 511-519.
43. Gregan J, Polakova S, Zhang L, Tolic-Norrelykke IM, Cimini D. 2011. Merotelic kinetochore attachment: Causes and effects. Trends Cell Biol 21: 374-381.
44. Gupta S. 2000. Hepatic polyploidy and liver growth control. Semin Cancer Biol 10: 161-171.
45. Gupta A, Inaba S, Wong OK, Fang G, Liu J. 2003. Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1. Oncogene 22: 7593-7599.
46. Habedanck R, Stierhof YD, Wilkinson CJ, Nigg EA. 2005. The Polo kinase Plk4 functions in centriole duplication. Nat Cell Biol 7: 1140-1146.
47. Hama A, Yagasaki H, Takahashi Y, Nishio N, Muramatsu H, Yoshida N, Tanaka M, Hidaka H, Watanabe N, Yoshimi A, et al. 2008. Acute megakaryoblastic leukaemia (AMKL) in children: A comparison of AMKL with and without Down syndrome. Br J Haematol 140: 552-561.
48. Hanks S, Coleman K, Reid S, Plaja A, Firth H, Fitzpatrick D, Kidd A, Mehes K, Nash R, Robin N, et al. 2004. Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat Genet 36: 1159-1161.
49. Hanna J, Hathaway NA, Tone Y, Crosas B, Elsasser S, Kirkpatrick DS, Leggett DS, Gygi SP, King RW, Finley D. 2006. Deubiquitinating enzyme Ubp6 functions noncatalytically to delay proteasomal degradation. Cell 127: 99-111.
50. Haruki N, Saito H, Harano T, Nomoto S, Takahashi T, Osada H, Fujii Y, Takahashi T. 2001. Molecular analysis of the mitotic checkpoint genes BUB1, BUBR1 and BUB3 in human lung cancers. Cancer Lett 162: 201-205.
51. Hassold TJ, Jacobs PA. 1984. Trisomy in man. Annu Rev Genet 18: 69-97.
52. Hassold T, Hall H, Hunt P. 2007. The origin of human aneuploidy: Where we have been, where we are going. Hum Mol Genet 16: R203-R208.
53. Hatch EM, Fischer AH, Deerinck TJ, Hetzer MW. 2013. Catastrophic nuclear envelope collapse in cancer cell micronuclei. Cell 154: 47-60.
54. Hayama S, Daigo Y, Kato T, Ishikawa N, Yamabuki T, Miyamoto M, Ito T, Tsuchiya E, Kondo S, Nakamura Y. 2006. Activation of CDCA1-KNTC2, members of centromere protein complex, involved in pulmonary carcinogenesis. Cancer Res 66: 10339-10348.
55. Heath EI, Hillman DW, Vaishampayan U, Sheng S, Sarkar F, Harper F, Gaskins M, Pitot HC, TanW, Ivy SP, et al. 2008. A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer. Clin Cancer Res 14: 7940-7946.
56. Hernando E, Nahle Z, Juan G, Diaz-Rodriguez E, Alaminos M, Hemann M, Michel L, Mittal V, Gerald W, Benezra R, et al. 2004. Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature 430: 797-802.
57. Holland AJ, Cleveland DW. 2009. Boveri revisited: Chromosomal instability, aneuploidy and tumorigenesis. Nat Rev Mol Cell Biol 10: 478-487.
58. Infante JR, Kurzrock R, Spratlin J, Burris HA, Eckhardt SG, Li J, Wu K, Skolnik JM, Hylander-Gans L, Osmukhina A, et al. 2012. A Phase I study to assess the safety, tolerability, and pharmacokinetics of AZD4877, an intravenous Eg5 inhibitor in patients with advanced solid tumors. Cancer Chemother Pharmacol 69: 165-172.
59. Iwanaga Y, Chi YH, Miyazato A, Sheleg S, Haller K, Peloponese JM Jr, Li Y, Ward JM, Benezra R, Jeang KT. 2007. Heterozygous deletion of mitotic arrest-deficient protein 1 (MAD1) increases the incidence of tumors in mice. Cancer Res 67: 160-166.
60. Janssen A, van der Burg M, Szuhai K, Kops GJ, Medema RH. 2011. Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations. Science 333: 1895-1898.
61. Jeganathan KB, Malureanu L, van Deursen JM. 2005. The Rae1-Nup98 complex prevents aneuploidy by inhibiting securin degradation. Nature 438: 1036-1039.
62. Jeganathan K, Malureanu L, Baker DJ, Abraham SC, van Deursen JM. 2007. Bub1 mediates cell death in response to chromosome missegregation and acts to suppress spontaneous tumorigenesis. J Cell Biol 179: 255-267.
63. Jiang J, Jing Y, Cost GJ, Chiang JC, Kolpa HJ, Cotton AM, Carone DM, Carone BR, Shivak DA, Guschin DY, et al. 2013. Translating dosage compensation to trisomy 21. Nature 500: 296-300.
64. Johnson E, Cotter FE. 1997. Monosomy 7 and 7q2 associated with myeloid malignancy. Blood Rev 11: 46-55.
65. Kabeche L, Compton DA. 2012. Checkpoint-independent stabilization of kinetochore-microtubule attachments by Mad2 in human cells. Curr Biol 22: 638-644.
66. Kalitsis P, Earle E, Fowler KJ, Choo KH. 2000. Bub3 gene disruption in mice reveals essential mitotic spindle checkpoint function during early embryogenesis. Genes Dev 14: 2277-2282.
67. Kalitsis P, Fowler KJ, Griffiths B, Earle E, Chow CW, Jamsen K, Choo KH. 2005. Increased chromosome instability but not cancer predisposition in haploinsufficient Bub3 mice. Genes Chromosomes Cancer 44: 29-36.
68. Kantarjian HM, Padmanabhan S, Stock W, Tallman MS, Curt GA, Li J, Osmukhina A, Wu K, Huszar D, Borthukar G, et al. 2012. Phase I/II multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4877 in patients with refractory acute myeloid leukemia. Invest New Drugs 30: 1107-1115.
69. Kingsbury MA, Friedman B, McConnell MJ, Rehen SK, Yang AH, Kaushal D, Chun J. 2005. Aneuploid neurons are functionally active and integrated into brain circuitry. Proc Natl Acad Sci 102: 6143-6147.
70. Kops GJ, Foltz DR, Cleveland DW. 2004. Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint. Proc Natl Acad Sci 101: 8699-8704.
71. Korbel JO, Tirosh-Wagner T, Urban AE, Chen XN, Kasowski M, Dai L, Grubert F, Erdman C, Gao MC, Lange K, et al. 2009. The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies. Proc Natl Acad Sci 106: 12031-12036.
72. Kwon M, Godinho SA, Chandhok NS, Ganem NJ, Azioune A, Thery M, Pellman D. 2008. Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes. Genes Dev 22: 2189-2203.
73. Lengauer C, Kinzler KW, Vogelstein B. 1997. Genetic instability in colorectal cancers. Nature 386: 623-627.
74. Li GQ, Li H, Zhang HF. 2003. Mad2 and p53 expression profiles in colorectal cancer and its clinical significance. World J Gastroenterol 9: 1972-1975.
75. Li M, Fang X, Baker DJ, Guo L, Gao X, Wei Z, Han S, van Deursen JM, Zhang P. 2010. The ATM-p53 pathway suppresses aneuploidy-induced tumorigenesis. Proc Natl Acad Sci 107: 14188-14193.
76. Lingle WL, Barrett SL, Negron VC, D’Assoro AB, Boeneman K, Liu W, Whitehead CM, Reynolds C, Salisbury JL. 2002. Centrosome amplification drives chromosomal instability in breast tumor development. Proc Natl Acad Sci 99: 1978-1983.
77. Logarinho E, Maffini S, Barisic M, Marques A, Toso A, Meraldi P, Maiato H. 2012. CLASPs prevent irreversible multipolarity by ensuring spindle-pole resistance to traction forces during chromosome alignment. Nat Cell Biol 14: 295-303.
78. Marthiens V, Rujano MA, Pennetier C, Tessier S, Paul-Gilloteaux P, Basto R. 2013. Centrosome amplification causes microcephaly. Nat Cell Biol 15: 731-740.
79. Matsuura S, Matsumoto Y, Morishima K, Izumi H, Matsumoto H, Ito E, Tsutsui K, Kobayashi J, Tauchi H, Kajiwara Y, et al. 2006.Monoallelic BUB1B mutations and defective mitotic-spindle checkpoint in seven families with premature chromatid separation (PCS) syndrome. Am J Med Genet A 140: 358-367.
80. McClintock B. 1941. The stability of broken ends of chromosomes in Zea Mays. Genetics 26: 234-282.
81. McKenna RW. 2004. Myelodysplasia and myeloproliferative disorders in children. AmJ Clin Pathol 122 (Suppl): S58-S69.
82. Michel LS, Liberal V, Chatterjee A, Kirchwegger R, Pasche B, Gerald W, Dobles M, Sorger PK, Murty VV, Benezra R. 2001. MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 409: 355-359.
83. Mitelman F, Heim S, Mandahl N. 1990. Trisomy 21 in neoplastic cells. Am J Med Genet 7 (Suppl): 262-266.
84. Mitelman F, Johansson B, Mertens F (eds.). 2013. Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer, cgap.nci.nih.gov/Chromosomes/Mitelman.
85. Musacchio A, Salmon ED. 2007. The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 8: 379-393.
86. Myrie KA, Percy MJ, Azim JN, Neeley CK, Petty EM. 2000. Mutation and expression analysis of human BUB1 and BUB1B in aneuploid breast cancer cell lines. Cancer Lett 152: 193-199.
87. Nasmyth K. 2011. Cohesin: A catenase with separate entry and exit gates? Nature Cell Biol 13: 1170-1177.
88. Oromendia AB, Dodgson SE, Amon A. 2012. Aneuploidy causes proteotoxic stress in yeast. Genes Dev 26: 2696-2708.
89. Park HY, Jeon YK, Shin HJ, Kim IJ, Kang HC, Jeong SJ, Chung DH, Lee CW. 2007. Differential promoter methylation may be a key molecular mechanism in regulating BubR1 expression in cancer cells. Exp Mol Med 39: 195-204.
90. Paulsson K, Johansson B. 2007. Trisomy 8 as the sole chromosomal aberration in acutemyeloid leukemia andmyelodysplastic syndromes. Pathol Biol (Paris) 55: 37-48.
91. Pavelka N, Rancati G, Zhu J, Bradford WD, Saraf A, Florens L, Sanderson BW, Hattem GL, Li R. 2010. Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast. Nature 468: 321-325.
92. Perera D, Tilston V, Hopwood JA, Barchi M, Boot-Handford RP, Taylor SS. 2007. Bub1 maintains centromeric cohesion by activation of the spindle checkpoint. Dev Cell 13: 566-579.
93. Pérez de Castro I, de Cárcer G, Malumbres M. 2007.Acensus of mitotic cancer genes: New insights into tumor cell biology and cancer therapy. Carcinogenesis 28: 899-912.
94. Peth A, Besche HC, Goldberg AL. 2009. Ubiquitinated proteins activate the proteasome by binding toUsp14/Ubp6, which causes 20S gate opening. Mol Cell 36: 794-804.
95. Pinsky BA, Kung C, Shokat KM, Biggins S. 2006. The Ipl1-Aurora protein kinase activates the spindle checkpoint by creating unattached kinetochores. Nat Cell Biol 8: 78-83.
96. Primorac I, Musacchio A. 2013. Panta rhei: The APC/C at steady state. J Cell Biol 201: 177-189.
97. Putkey FR, Cramer T, Morphew MK, Silk AD, Johnson RS, McIntosh JR, Cleveland DW. 2002. Unstable kinetochore-microtubule capture and chromosomal instability following deletion of CENP-E. Dev Cell 3: 351-365.
98. Rao CV, Yang YM, Swamy MV, Liu T, Fang Y, Mahmood R, Jhanwar-Uniyal M, Dai W. 2005. Colonic tumorigenesis in BubR1þ/2ApcMin/þ compound mutant mice is linked to premature separation of sister chromatids and enhanced genomic instability. Proc Natl Acad Sci 102: 4365-4370.
99. Rausch T, Jones DT, Zapatka M, Stutz AM, Zichner T, Weischenfeldt J, Jager N, Remke M, Shih D, Northcott PA, et al. 2012. Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell 148: 59-71.
100. Ravid K, Lu J, Zimmet JM, Jones MR. 2002. Roads to polyploidy: The megakaryocyte example. J Cell Physiol 190: 7-20.
101. Reddy SK, Rape M, Margansky WA, Kirschner MW. 2007. Ubiquitination by the anaphase-promoting complex drives spindle checkpoint inactivation. Nature 446: 921-925.
102. Rocquain J, Gelsi-Boyer V, Adelaide J, Murati A, Carbuccia N, Vey N, Birnbaum D, Mozziconacci MJ, Chaffanet M. 2010. Alteration of cohesin genes inmyeloid diseases. Am J Hematol 85: 717-719.
103. Saif MW, Erlichman C, Dragovich T, Mendelson D, Toft D, Burrows F, Storgard C, Von Hoff D. 2013. Open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of intravenously administered CNF 1010 (17-[allylamino]-17-demethoxygeldanamycin [17-AAG]) in patients with solid tumors. Cancer Chemother Pharmacol 71: 1345-1355.
104. Satge D, Sommelet D, Geneix A, Nishi M, Malet P, Vekemans M. 1998. A tumor profile in Down syndrome. Am J Med Genet 78: 207-216.
105. Schvartzman JM, Duijf PH, Sotillo R, Coker C, Benezra R. 2011. Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition. Cancer Cell 19: 701-714.
106. Segal DJ, McCoy EE. 1974. Studies on Down’s syndrome in tissue culture: I. Growth rates and protein contents of fibroblast cultures. J Cell Physiol 83: 85-90.
107. Senovilla L, Vitale I, Martins I, Tailler M, Pailleret C, Michaud M, Galluzzi L, Adjemian S, Kepp O, Niso-Santano M, et al. 2012. An immunosurveillance mechanism controls cancer cell ploidy. Science 337: 1678-1684.
108. Sheltzer JM, Blank HM, Pfau SJ, Tange Y, George BM, Humpton TJ, Brito IL, Hiraoka Y, Niwa O, Amon A. 2011. Aneuploidy drives genomic instability in yeast. Science 333: 1026-1030.
109. Sheltzer JM, Torres EM, Dunham MJ, Amon A. 2012. Transcriptional consequences of aneuploidy. Proc Natl Acad Sci 109: 12644-12649.
110. Silkworth WT, Nardi IK, Scholl LM, Cimini D. 2009. Multipolar spindle pole coalescence is a major source of kinetochore mis-attachment and chromosome missegregation in cancer cells. PloS ONE 4: e6564.
111. Snape K, Hanks S, Ruark E, Barros-Nunez P, Elliott A, Murray A, Lane AH, Shannon N, Callier P, Chitayat D, et al. 2011. Mutations in CEP57 cause mosaic variegated aneuploidy syndrome. Nat Genet 43: 527-529.
112. Solit DB, Osman I, Polsky D, Panageas KS, Daud A, Goydos JS, Teitcher J, Wolchok JD, Germino FJ, Krown SE, et al. 2008. Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma. Clin Cancer Res 14: 8302-8307.
113. Solomon DA, Kim T, Diaz-Martinez LA, Fair J, Elkahloun AG, Harris BT, Toretsky JA, Rosenberg SA, Shukla N, Ladanyi M, et al. 2011. Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science 333: 1039-1043.
114. Sotillo R, Hernando E, Diaz-Rodriguez E, Teruya-Feldstein J, Cordon-Cardo C, Lowe SW, Benezra R. 2007. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 11: 9-23.
115. Sotillo R, Schvartzman JM, Socci ND, Benezra R. 2010. Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal. Nature 464: 436-440.
116. Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ, Pleasance ED, Lau KW, Beare D, Stebbings LA, et al. 2011. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144: 27-40.
117. Stingele S, Stoehr G, Peplowska K, Cox J, Mann M, Storchova Z. 2012. Global analysis of genome, transcriptome and proteome reveals the response to aneuploidy in human cells. Mol Syst Biol 8: 608.
118. Storchova Z, Breneman A, Cande J, Dunn J, Burbank K, O’Toole E, Pellman D. 2006. Genome-wide genetic analysis of polyploidy in yeast. Nature 443: 541-547.
119. Tanaka K, Nishioka J, Kato K, Nakamura A, Mouri T, Miki C, Kusunoki M, Nobori T. 2001. Mitotic checkpoint protein hsMAD2 as a marker predicting liver metastasis of human gastric cancers. Jpn J Cancer Res 92: 952-958.
120. Tang YC, Williams BR, Siegel JJ, Amon A. 2011. Identification of aneuploidy-selective antiproliferation compounds. Cell 144: 499-512.
121. Terradas M, Martin M, Tusell L, Genesca A. 2010. Genetic activities in micronuclei: Is theDNA entrapped in micronuclei lost for the cell? Mutat Res 705: 60-67.
122. Thompson SL, Compton DA. 2008. Examining the link between chromosomal instability and aneuploidy in human cells. J Cell Biol 180: 665-672.
123. Thompson SL, Compton DA. 2010. Proliferation of aneuploid human cells is limited by a p53-dependent mechanism. J Cell Biol 188: 369-381.
124. Thompson SL, Compton DA. 2011a. Chromosome missegregation in human cells arises through specific types of kinetochore-microtubule attachment errors. Proc Natl Acad Sci 108: 17974-17978.
125. Thompson SL, Compton DA. 2011b. Chromosomes and cancer cells. Chromosome Res 19: 433-444.
126. Thompson SL, Bakhoum SF, Compton DA. 2010. Mechanisms of chromosomal instability. Curr Biol 20: R285-R295.
127. Tighe A, Johnson VL, Albertella M, Taylor SS. 2001. Aneuploid colon cancer cells have a robust spindle checkpoint. EMBO Rep 2: 609-614.
128. Tomasini R, Mak TW, Melino G. 2008. The impact of p53 and p73 on aneuploidy and cancer. Trends Cell Biol 18: 244-252.
129. Torres EM, Sokolsky T, Tucker CM, Chan LY, Boselli M, Dunham MJ, Amon A. 2007. Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science 317: 916-924.
130. Torres EM, Dephoure N, Panneerselvam A, Tucker CM, Whittaker CA, Gygi SP, Dunham MJ, Amon A. 2010. Identification of aneuploidy-tolerating mutations. Cell 143: 71-83.
131. Ullah Z, Lee CY, Lilly MA, DePamphilis ML. 2009. Developmentally programmed endoreduplication in animals. Cell Cycle 8: 1501-1509.
132. van Ree JH, Jeganathan KB, Malureanu L, van Deursen JM. 2010. Overexpression of the E2 ubiquitin-conjugating enzyme UbcH10 causes chromosome missegregation and tumor formation. J Cell Biol 188: 83-100.
133. Vargas JD, Hatch EM, Anderson DJ, Hetzer MW. 2012. Transient nuclear envelope rupturing during interphase in human cancer cells. Nucleus 3: 88-100.
134. Walter MJ, Payton JE, Ries RE, Shannon WD, Deshmukh H, Zhao Y, Baty J, Heath S, Westervelt P, Watson MA, et al. 2009. Acquired copy number alterations in adult acute myeloid leukemia genomes. Proc Natl Acad Sci 106: 12950-12955.
135. Wang RH, Yu H, Deng CX. 2004. A requirement for breastcancer-associated gene 1 (BRCA1) in the spindle checkpoint. Proc Natl Acad Sci 101: 17108-17113.
136. Weaver BA, Cleveland DW. 2006. Does aneuploidy cause cancer? Curr Opin Cell Biol 18: 658-667.
137. Weaver BA, Silk AD, Montagna C, Verdier-Pinard P, Cleveland DW. 2007. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 11: 25-36.
138. Welch JS, Ley TJ, Link DC, Miller CA, Larson DE, Koboldt DC, Wartman LD, Lamprecht TL, Liu F, Xia J, et al. 2012. The origin and evolution of mutations in acute myeloid leukemia. Cell 150: 264-278.
139. Williams BR, Prabhu VR, Hunter KE, Glazier CM, Whittaker CA, Housman DE, Amon A. 2008. Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells. Science 322: 703-709.
140. Xie C, Powell C, Yao M, Wu J, Dong Q. 2014. Ubiquitinconjugating enzyme E2C: A potential cancer biomarker. Int J Biochem Cell Biol 47: 113-117.
141. Yaffe D, Feldman M. 1965. The formation of hybrid multinucleated muscle fibers from myoblasts of different genetic origin. Dev Biol 11: 300-317.
142. Yurov YB, Iourov IY, Vorsanova SG, Liehr T, Kolotii AD, Kutsev SI, Pellestor F, Beresheva AK, Demidova IA, Kravets VS, et al. 2007. Aneuploidy and confined chromosomal mosaicism in the developing human brain. PloS ONE 2: e558.
143. Zack TI, Schumacher SE, Carter SL, Cherniack AD, Saksena G, Tabak B, Lawrence MS, Zhang CZ, Wala J, Mermel CH, et al. 2013. Pan-cancer patterns of somatic copy number alteration. Nat Genet 45: 1134-1140.
144. Zhang L, Taub JW, Williamson M, Wong SC, Hukku B, Pullen J, Ravindranath Y, Matherly LH. 1998. Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: Relationship to immunophenotype and ploidy. Clin Cancer Res 4: 2169-2177.
145. Zhu J, Pavelka N, Bradford WD, Rancati G, Li R. 2012. Karyotypic determinants of chromosome instability in aneuploid budding yeast. PLoS Genet 8: e1002719.
146. Zhuang Z, Park WS, Pack S, Schmidt L, Vortmeyer AO, Pak E, Pham T, Weil RJ, Candidus S, Lubensky IA, et al. 1998. Trisomy 7-harbouring non-random duplication of the mutant METallele in hereditary papillary renal carcinomas. Nat Genet 20: 66-69.